Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,000
Closed -$14.7K 4395
2025
Q3
$14.7K Hold
1,000
﹤0.01% 2557
2025
Q2
$9.82K Hold
1,000
﹤0.01% 2739
2025
Q1
$7.27K Hold
1,000
﹤0.01% 2612
2024
Q4
$7.82K Buy
+1,000
New +$8.23K ﹤0.01% 2623

Other funds holding ETNB

MAI Capital Management's ETNB Position: Q4 2025 in Review

MAI Capital Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 1,000 shares — an estimated $14.7K sold.

MAI Capital Management first reported a position in ETNB in Q4 2024 and held it in 4 quarters. The position peaked at $14.7K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • MAI Capital Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • MAI Capital Management sold 1,000 89bio shares in Q4 2025, an estimated $14.7K.
  • MAI Capital Management first reported a position in 89bio in Q4 2024 and held it in 4 quarters.
  • MAI Capital Management's 89bio position peaked at $14.7K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on MAI Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.